Hoffmann-La Roche: Diabetes Mellitus trials
The registry lists 12 Diabetes Mellitus studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 3Phase 2 3Phase 3 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes MellitusCompletedNCT03445065Not applicableResults posted
- A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)CompletedNCT00473382Phase 3Results posted
- A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)CompletedNCT00473330Phase 3Results posted
- A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood GlucoseCompletedNCT04973111Phase 1
- A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes MellitusCompletedNCT04838405Phase 1
- Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in PakistanCompletedNCT02444845
- A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.CompletedNCT02156349Not applicable
- Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBGTerminatedNCT01820169Not applicable
- A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot UlcersCompletedNCT00351767Phase 2
- A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot UlcersCompletedNCT00069446Phase 1
- Study of Ro 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057317Phase 2
- Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057304Phase 2